SC 13G: ORAGENICS INC
Ticker: OGEN · Form: SC 13G · Filed: Sep 11, 2024 · CIK: 1174940
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by ORAGENICS INC.
Risk Assessment
Risk Level: low
Filing Stats: 2,236 words · 9 min read · ~7 pages · Grade level 10.8 · Accepted 2024-09-11 07:45:36
Key Financial Figures
- $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securiti
Filing Documents
- c110042_sc13g.htm (SC 13G) — 48KB
- c110042_ex-1.htm (EX-1) — 4KB
- 0000930413-24-002747.txt ( ) — 53KB
(a)
Item 2 (a). Name of Person Filing
(b)
Item 2 (b). Address of Principal Business Office or, if none, Residence
(c)
Item 2 (c). Citizenship This Schedule 13G is being filed on behalf of (i) Iroquois Capital Management L.L.C., a Delaware limited liability company (“Iroquois”), (ii) Richard Abbe, an individual who is a citizen of the United States of America and (iii) Kimberly Page, an individual who is a citizen of the United The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended. The principal business office of all of the Reporting Persons is 2 Overhill Road, Scarsdale, New York 10583.
(d)
Item 2 (d) Title of Class of Securities Common Stock, par value $0.001 per share
(e)
Item 2 (e) CUSIP Number 684023500 Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: Not applicable. (a) o Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) o Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) o Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) o Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) o A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) o A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) o A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) o A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); (k) o Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Ownership
Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. The information as of the date of the event which requires filing of this statement required by Items 4(a) – (c) is set forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The percentage set forth in Row 11 of the cover page for each Reporting Person is based on 8,659,071 shares of Common Stock issued and outstanding as of September 5, 2024 as represented in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2024, and assumes the exercise of the Company’s reported pre-funded warrants (the “Reported Pre-Funded Warrants”), subject to the Blocker (as defined below). Pursuant to the terms of the Reported Pre-Funded Warrants, the Reporting Persons cannot exercise the Pre-Funded Warrants to the extent the Reporting Persons would beneficially own, after any such exercise, more than 9.99% of the outstanding shares of Common Stock (the “Blocker”), and the percentage set forth in Row 11 of the cover page for each Reporting Person gives effect to the Blocker. Consequently, as of the date of the event which requires the filing of this statement, the Reporting Persons were not able to exercise all of the Reported Pre-Funded Warrants due to the Blocker. As of the date of the event which requires filing of this statement, Iroquois Master Fund Ltd. (“Iroquois Master Fund”) held 606,818 shares of Common Stock and Pre-Funded Warrants to purchase 75,000 shares of Common Stock (subject to the Blocker), and Iroquois Capital Investment Group LLC (“ICIG”) held 202,272 shares of Common Stock and Pre-Funded Warrants to purchase 25,000 shares of Common (subject to the Blocker). Mr. Abbe shares authority and res
Ownership
Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: o
Ownership
Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable.
Identification
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person Not applicable.
Identification
Item 8. Identification and Classification of Members of the Group See Exhibit 1.
Notice
Item 9. Notice of Dissolution of Group Not applicable.
Certification
Item 10. Certification By signing below each of the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: September 10, 2024 IROQUOIS CAPITAL MANAGEMENT L.L.C. By: /s/ Richard Abbe Richard Abbe, President /s/ Richard Abbe Richard Abbe /s/ Kimberly Page Kimberly Page EXHIBIT INDEX Exhibit 1 Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.